Joon Chang Selected Research

Idiopathic Pulmonary Fibrosis

5/2021	Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study.
12/2020	Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital.
3/2018	Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation.
11/2013	Spontaneous regression of non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.
4/2013	TGF-β1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joon Chang Research Topics

Disease

27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2003
19	Neoplasms (Cancer) 01/2020 - 06/2003
13	Infections 08/2021 - 02/2007
10	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2003
9	Tuberculosis (Tuberculoses) 12/2020 - 09/2005
9	Adenocarcinoma 10/2013 - 06/2004
6	Critical Illness (Critically Ill) 02/2020 - 09/2012
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2013 - 10/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012 - 06/2004
5	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 05/2010
5	Idiopathic Pulmonary Fibrosis 05/2021 - 04/2013
5	Sepsis (Septicemia) 05/2020 - 11/2011
5	Lung Injury 01/2019 - 07/2015
5	Septic Shock (Toxic Shock Syndrome) 12/2017 - 08/2011
5	Latent Tuberculosis 01/2017 - 12/2009
5	Disease Progression 06/2013 - 10/2002
4	Pneumonia (Pneumonitis) 01/2019 - 03/2011
4	Inflammation (Inflammations) 01/2018 - 01/2015
4	Pleural Effusion (Pleural Effusions) 12/2012 - 08/2004
3	Lung Diseases (Lung Disease) 03/2018 - 10/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 06/2011
3	Neoplasm Metastasis (Metastasis) 09/2013 - 06/2005
2	Lymphopenia (Lymphocytopenia) 10/2020 - 01/2019
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2019 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 09/2002
2	Bronchiectasis 01/2017 - 09/2003
2	Airway Obstruction (Choking) 01/2016 - 01/2015
2	Carcinogenesis 07/2015 - 06/2004
2	Adenocarcinoma of Lung 03/2014 - 01/2014
2	Bacteremia 08/2012 - 07/2010
2	Respiratory Insufficiency (Respiratory Failure) 08/2012 - 07/2010
2	Acute Lung Injury 08/2011 - 06/2011
2	Carcinoma (Carcinomatosis) 11/2004 - 06/2003

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 05/2017 - 06/2004
9	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2007
7	Proteins (Proteins, Gene)FDA Link 03/2017 - 11/2004
6	Pharmaceutical PreparationsIBA 12/2020 - 05/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2003
5	Gefitinib (Iressa)FDA Link 09/2012 - 12/2003
4	LigandsIBA 01/2018 - 07/2015
4	Tuberculin (PPD)IBA 01/2018 - 12/2009
4	EphA2 ReceptorIBA 01/2018 - 07/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 08/2013 - 05/2010
4	Cisplatin (Platino)FDA LinkGeneric 06/2013 - 12/2006
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2012 - 06/2007
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2010 - 12/2006
3	BilirubinIBA 02/2020 - 12/2017
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2010
3	Monoclonal AntibodiesIBA 01/2018 - 07/2015
3	Insulin-Like PeptidesIBA 01/2018 - 01/2006
3	LipopolysaccharidesIBA 01/2018 - 07/2015
3	CytokinesIBA 01/2018 - 04/2013
3	Cadherins (E-Cadherin)IBA 11/2016 - 09/2013
3	Immunoglobulin G (IgG)IBA 11/2016 - 07/2015
3	Phosphotransferases (Kinase)IBA 10/2013 - 02/2007
3	antigen CYFRA21.1IBA 09/2012 - 07/2011
3	Keratin-19 (Keratin 19)IBA 09/2012 - 07/2011
3	Carcinoembryonic AntigenIBA 09/2012 - 07/2011
3	Adenosine Triphosphate (ATP)IBA 10/2009 - 08/2005
2	AutoantibodiesIBA 05/2021 - 01/2017
2	pirfenidoneIBA 05/2021 - 12/2020
2	SteroidsIBA 10/2020 - 01/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 05/2020 - 11/2011
2	AlbuminsIBA 02/2020 - 10/2018
2	GoldIBA 01/2020 - 07/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 12/2012
2	C-Reactive ProteinIBA 10/2018 - 11/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 01/2014
2	AntioxidantsIBA 01/2018 - 01/2016
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 12/2008
2	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2014
2	Eph Family Receptors (Eph Receptors)IBA 01/2018 - 07/2015
2	Insulin (Novolin)FDA Link 01/2018 - 12/2008
2	EphrinsIBA 12/2017 - 07/2015
2	Tumor Necrosis Factor InhibitorsIBA 01/2017 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 10/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017 - 06/2004
2	SmokeIBA 01/2016 - 01/2010
2	belotecanIBA 06/2013 - 10/2010
2	Tumor Biomarkers (Tumor Markers)IBA 09/2012 - 08/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2011 - 06/2011
2	pro-brain natriuretic peptide (1-76)IBA 08/2011 - 06/2011
2	Interferon-gamma (Interferon, gamma)IBA 09/2010 - 12/2009
2	Topotecan (Hycamtin)FDA LinkGeneric 02/2008 - 10/2002
2	PlatinumIBA 02/2008 - 05/2007
2	Etoposide (VP 16)FDA LinkGeneric 02/2008 - 10/2002
2	Insulin-Like Growth Factor Binding Protein 3IBA 06/2006 - 01/2006
2	retinoic acid receptor betaIBA 06/2006 - 06/2004
2	Adenosine DeaminaseIBA 09/2005 - 08/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2021

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 06/2015 - 10/2002
5	Therapeutics 01/2019 - 10/2004
4	Lung Transplantation 03/2018 - 11/2016
3	Radiotherapy 01/2019 - 05/2007
2	Artificial Respiration (Mechanical Ventilation) 03/2017 - 07/2010
2	Enteral Nutrition (Feeding, Tube) 09/2012 - 03/2011
2	Central Venous Catheters 08/2012 - 07/2010
1	Baths 08/2021